Search Within

Jorge Sergio Reis-Filho

  1. "GSK Faculty"
Formats
  1. Journal Article (314)
  2. Meeting Abstract (289)
  3. Review (20)
  4. Book Section (6)
  5. Editorial (4)
  6. Guidelines (4)
  7. Conference Paper (1)
  8. Correspondence (1)
Groups
  1. GSK Faculty (639)
  2. Department of Pathology and Laboratory Medicine (514)
  3. Gynecology Disease Management Team (406)
  4. GDMT, Pathology and Laboratory Medicine (404)
  5. Sloan Kettering Institute Postdocs (327)
  6. Department of Medicine (244)

More Groups

People
  1. Britta Weigelt (402)
  2. Fresia Pareja Zea (166)
  3. Kiu Yan Charlotte Ng (153)
  4. Pier Selenica (140)
  5. Hannah Wen (127)
  6. Edi Brogi (126)

More People

Years
  1. 2025 (9)
  2. 2024 (30)
  3. 2023 (55)
  4. 2022 (55)
  5. 2021 (45)
  6. 2020 (93)

More Years

Publications
  1. Modern Pathology (89)
  2. Cancer Research (82)
  3. Laboratory Investigation (78)
  4. Annals of Oncology (27)
  5. npj Breast Cancer (27)
  6. Journal of Clinical Oncology (25)

More Publications

Publishers
  1. Nature Publishing Group (164)
  2. American Association for Cancer Research (115)
  3. Nature Research (92)
  4. Wiley Blackwell (49)
  5. Oxford University Press (45)
  6. Elsevier Inc. (38)

More Publishers

Results (639)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An AI-driven computational biomarker from H&E slides recovers cases with low levels of HER2 from immunohistochemically HER2-negative breast cancers
    Meeting Abstract

    Marra, A.; Goldfinger, M.; Millar, E.; Hanna, M.; Rothrock, B.; Lee, M.; Wang, Y.; van Eck, A.; Tydlitatova, L. T.; Sue, J.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Mutational signature analysis reveals patterns of genomic instability linked to resistance to endocrine therapy (ET) +/- CDK 4/6 inhibition (CDK4/6i) in estrogen receptor-positive/HER2-negative (ER+/HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Marra, A.; Gazzo, A.; Gupta, A.; Selenica, P.; Da Silva, E. M.; Pareja, F.; Pei, X.; Zhu, Y.; Razavi, P.; Safonov, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Single-cell genomic variation induced by mutational processes in cancer
    Journal Article

    Funnell, T.; O’Flanagan, C. H.; Williams, M. J.; McPherson, A.; McKinney, S.; Kabeer, F.; Lee, H.; Salehi, S.; Vázquez-García, I.; Shi, H.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas
    Journal Article

    Selenica, P.; Marra, A.; Choudhury, N. J.; Gazzo, A.; Falcon, C. J.; Patel, J.; Pei, X.; Zhu, Y.; Ng, C. K. Y.; Curry, M.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling of cell-free circulating tumor DNA detects response to ribociclib plus letrozole in a patient with metastatic breast cancer
    Journal Article

    Silveira, C.; Sousa, A. C.; Corredeira, P.; Martins, M.; Sousa, A. R.; Da Cruz Paula, A.; Selenica, P.; Brown, D. N.; Golkaram, M.; Kaplan, S.; more...
    Biomolecules (2022)

    Fulltext@MSK | Save
  • Impact of clonal hematopoiesis on tumor control following radiation therapy
    Meeting Abstract

    Tao, J.; Setton, J.; Vela, P. S.; Safonov, A. M.; Comen, E. A.; Braunstein, L. Z.; Reis-Filho, J. S.; Riaz, N.; Powell, S. N.; Levine, R. L.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Allelic dosage of RB1 drives CDK4/6 inhibitor treatment resistance in metastatic breast cancer
    Meeting Abstract

    Safonov, A. M.; Bandlamudi, C.; Selenica, P.; Marra, A.; Ferraro, E.; Mandelker, D.; Solit, D. B.; Berger, M. F.; Norton, L.; Powell, S. N.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Minimal residual disease (MRD) detection by ctDNA in relation to radiographic disease progression in patients with stage I-III non-small cell lung cancer (NSCLC) treated with definitive radiation therapy
    Meeting Abstract

    Lebow, E. S.; Murciano-Goroff, Y. R.; Jee, J.; Kalashnikova, E.; Feeney, J.; Sethi, H.; Aleshin, A.; Kris, M. G.; Chaft, J. E.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Identification of pretreatment genomic biomarkers and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers
    Meeting Abstract

    Choudhury, N. J.; Marra, A.; Yang, S. R.; Falcon, C. J.; Heller, G.; Kris, M. G.; Reis-Filho, J. S.; Riely, G. J.; Yu, H. A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save